Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized Approach
Gastroenterology, Volume 134, No. 2, Year 2008
Notification
URL copied to clipboard!
Description
Treatment of chronic hepatitis B virus (HBV) infection is aimed at suppressing viral replication to the lowest possible level, and thereby to halt the progression of liver disease and prevent the onset of complications. Two categories of drugs are used in HBV therapy: the interferons, including standard interferon alfa or pegylated interferon alfa, and specific nucleoside or nucleotide HBV inhibitors that target the reverse-transcriptase function of HBV-DNA polymerase. The reported results of clinical trials have used varying definitions of efficacy, failure, and resistance based on different measures of virologic responses. This article discusses HBV virologic markers and tests, and their optimal use both for planning and reporting clinical trials and in clinical practice. © 2008 AGA Institute.
Authors & Co-Authors
Pawlotsky, Jean Michel
France, Creteil
Université Paris-est Créteil Val de Marne
France, Paris
Inserm
Dusheiko, Geoffrey M.
United Kingdom, London
Ucl Medical School
Hatzakis, Angelos E.
Greece, Athens
School of Medicine
Lau, George K K Ka Kit
Hong Kong
Queen Mary Hospital Hong Kong
Liang, Jake Jake
United States, Bethesda
National Institutes of Health Nih
Locarnini, Stephen A.
Australia
Victorian Infectious Diseases Reference Laboratory
Martin, Paul M.
United States, New York
Icahn School of Medicine at Mount Sinai
Richman, Douglas D.
United States, San Diego
Uc San Diego Health
Zoulim, Fabien
France, Lyon
Chu de Lyon
Statistics
Citations: 201
Authors: 9
Affiliations: 11
Identifiers
Doi:
10.1053/j.gastro.2007.11.036
ISSN:
00165085
Research Areas
Genetics And Genomics
Infectious Diseases